FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 60687-556 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerAmerican Health Packaging
Marketing categoryAbbreviated NDA (generic) · App ANDA207873
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (400 mg/1)
Marketing started20210420
Package count1

External sources

Source: openFDA. Public-domain (CC0).